This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Multiple Sclerosis/ Demyelinating Disease  • Radiologic Imaging  • Magnetic Resonance Imaging  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Connecting the Pixels

Arch Neurol. 2005;62:1666-1668.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The advent of magnetic resonance imaging (MRI) has been one of the most important advances in the understanding of multiple sclerosis (MS) over the past 25 years. Arguably, current MS therapies would not exist without MRI confirmation of their efficacy. The capabilities of MRI have captured the imaginations of clinicians and researchers and have helped spark increasing interest in the field of neuroimmunology.

Nonetheless, an uneasiness regarding the relationship of MRI findings to MS was present from the beginning. Although modest correlations could be made between MRI results and MS symptoms and disability in a population-based approach, it was difficult to translate these to an individual patient. The "MRI paradox," that lesions identified on routine MRI do not correlate well with patient symptoms and neurologic signs, is evident not just to researchers, but also to individual practicing clinicians. Thus, new and refined imaging techniques for MS have been under continual . . . [Full Text of this Article]

FACTS


FACTS IN DISPUTE

AUTHOR INFORMATION
Robert T. Naismith, MD; Anne H. Cross, MD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?